A06.8 Amebic infection of other sites

Name of the Condition

• Amebic infection of other sites (ICD-10-CM Code: A06.8)

Summary

Amebic infection of other sites refers to extraintestinal manifestations of Entamoeba histolytica infection, where the parasite invades tissues outside the intestines. Common sites include the liver, lungs, or brain, though other organs may be affected. The condition arises from the spread of the parasite beyond the gastrointestinal tract and can present with localized symptoms depending on the involved site.

Causes

Amebic infection of other sites is caused by the protozoan parasite Entamoeba histolytica. The parasite typically spreads from the intestines to other organs via the bloodstream or direct extension. Transmission occurs through ingestion of cysts, often from contaminated food or water, which then invade the intestinal lining and may disseminate to distant sites.

Risk Factors

• Living in or traveling to regions with poor sanitation.
• Consuming contaminated food or water.
• Weakened immune system, which may increase susceptibility to severe disease.
• Close contact with an infected individual or exposure to fecal matter.

Symptoms

• Site-specific symptoms depending on the affected organ (e.g., right upper quadrant pain or jaundice for liver involvement).
• Fever and systemic signs of infection.
• Cough or chest pain if the lungs are involved.
• Neurological symptoms (e.g., headache, confusion) if the brain is affected.
• Generalized fatigue and weight loss.

Diagnosis

Diagnosis involves identifying Entamoeba histolytica in tissue samples or bodily fluids from the affected site. Serological tests may detect antibodies, and imaging studies (e.g., ultrasound, CT, or MRI) can assess organ involvement. Stool examination may also be performed to confirm intestinal infection, as extraintestinal disease often originates from the gut.

Treatment Options

• Antiparasitic medications (e.g., metronidazole or tinidazole) to target active infection.
• Follow-up therapy with luminal agents (e.g., paromomycin) to eliminate intestinal cysts and prevent recurrence.
• Supportive care, including hydration and management of organ-specific complications (e.g., drainage of liver abscesses).

Prognosis and Follow-Up

Prognosis depends on the site and severity of infection, as well as timely treatment. Early intervention typically leads to favorable outcomes, but delayed care may result in permanent organ damage. Follow-up includes monitoring for recurrence or complications, especially in immunocompromised individuals.

Complications

• Organ damage (e.g., liver abscess, lung infection, or brain lesions).
• Sepsis or systemic infection.
• Chronic disability from untreated or severe disease.

Lifestyle & Prevention

• Avoid consuming untreated water or food in regions with poor sanitation.
• Practice good hygiene, including handwashing after using the restroom or handling food.
• Cook food thoroughly and avoid raw produce in high-risk areas.
• Seek prompt treatment for intestinal amebiasis to prevent spread.

When to Seek Professional Help

• Persistent or worsening symptoms (e.g., fever, pain, or neurological changes).
• Signs of organ-specific complications (e.g., jaundice, difficulty breathing, or confusion).
• Recent travel to endemic areas with suspected exposure.

Tips for Medical Coders

• Code A06.8 is used when the amebic infection involves sites other than the intestines, such as the liver, lungs, or brain.
• Documentation should specify the affected site (e.g., "amebic liver abscess" or "amebic pulmonary infection") to support the code assignment.
• Ensure the diagnosis aligns with clinical findings and testing (e.g., imaging or tissue biopsy) to confirm extraintestinal involvement.